Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes—an ENSAT cohort study

Key Points

• This research aims to evaluate the clinical management and outcomes of patients with different histological subtypes of adrenal cortical carcinoma.
• Analyzed data from the ENSAT cohort specifically for adrenal cortical carcinoma patients.
• Compared outcomes among various histological subtypes including oncocytic ACC.
• Adjusted outcomes based on cancer stage to evaluate survival rates.
• Oncocytic ACC demonstrated better stage-adjusted outcomes compared to other subtypes.
• Survival rates varied significantly among different histological subtypes of adrenal cortical carcinoma.